Alibaba Health's Qinglizi AI partners with NEJM, JAMA, and BMJ

Alibaba Health's AI platform, "Qinglizi" (Hydrogen Ion), has secured content partnerships with three top-tier medical journals: The New England Journal of Medicine (NEJM), JAMA, and The BMJ. This makes Qinglizi the first medical AI platform in China to have full-text content access and AI-powered Q&A capabilities for these prestigious publications. The platform aims to provide Chinese doctors with easier access to cutting-edge medical evidence, overcoming barriers such as cost, language, and retrieval efficiency, thereby supporting clinical and research decision-making. AI

IMPACT Enhances access to medical research for Chinese doctors, potentially improving clinical decision-making and research.

RANK_REASON Partnership between an AI platform and major medical journals for content access.

Read on 量子位 (QbitAI) →

• JAMA Network Open
• PubMed
• The BMJ
• The Journal of the American Medical Association
• The New England Journal of Medicine

• product
• paper

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →